retatrutide clinical trial weight loss New Phase 3 data just dropped 👀 Eli Lilly's reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats First Retatrutide phase 3 data,

Gut Microbes 2023;15:2274124

Its the difference between receiving a prescription and receiving care

Along with the blockbuster sales have come reports of serious health risks that were not fully described on the initial drug labels, including gastrointestinal problems like stomach paralysis and non-arteritic anterior ischemic optic neuropathy (NAION), a rare but serious form of optic-nerve damage that can cause permanent blindness

Living Your Healthiest Semaglutide Life: A Complete Guide to Nutrition and Mindset While on GLP-1 Medications - Kindle edition by Kessel, Summer

The massive weight-loss numbers you see in commercials, 15% to 20% body-weight loss, come from high therapeutic doses in controlled clinical trials

A NASH mouse study confirmed that using vitamin A-modified liposomes to target hepatic stellate cells (HSCs) and deliver SREBP2-siRNA or anti-miR-33a can reduce cholesterol accumulation in activated HSCs, thereby significantly improving liver fibrosis